Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis

Introduction: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, which is among the most lethal tumours. Combination therapy exploits multiple drugs to target key pathways synergistically to reduce tumour growth. Isothiocyanates have been shown to possess anticancer potential an...

Descripción completa

Detalles Bibliográficos
Autores principales: Strusi, Gabriele, Suelzu, Caterina M., Horwood, Nicole, Münsterberg, Andrea E., Bao, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583560/
https://www.ncbi.nlm.nih.gov/pubmed/37860118
http://dx.doi.org/10.3389/fphar.2023.1264032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583560/
https://www.ncbi.nlm.nih.gov/pubmed/37860118
http://dx.doi.org/10.3389/fphar.2023.1264032

Ejemplares similares